These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 16246391
1. CTL escape and increased viremia irrespective of HIV-specific CD4+ T-helper responses in two HIV-infected individuals. Geels MJ, Jansen CA, Baan E, De Cuyper IM, van Schijndel GJ, Schuitemaker H, Goudsmit J, Pollakis G, Miedema F, Paxton WA, van Baarle D. Virology; 2006 Feb 05; 345(1):209-19. PubMed ID: 16246391 [Abstract] [Full Text] [Related]
2. Selection of escape mutation by Pol154-162-specific cytotoxic T cells among chronically HIV-1-infected HLA-B*5401-positive individuals. Hashimoto M, Kitano M, Honda K, Koizumi H, Dohki S, Oka S, Takiguchi M. Hum Immunol; 2010 Feb 05; 71(2):123-7. PubMed ID: 19891998 [Abstract] [Full Text] [Related]
3. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy. Zhang Z, Zhao QX, Fu JL, Yao JX, He Y, Jin L, Wang FS. Chin Med J (Engl); 2006 Dec 05; 119(23):1949-57. PubMed ID: 17199938 [Abstract] [Full Text] [Related]
4. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection. Borghan MA, Oka S, Takiguchi M. Tissue Antigens; 2005 Oct 05; 66(4):305-13. PubMed ID: 16185326 [Abstract] [Full Text] [Related]
5. Evolution and transmission of stable CTL escape mutations in HIV infection. Goulder PJ, Brander C, Tang Y, Tremblay C, Colbert RA, Addo MM, Rosenberg ES, Nguyen T, Allen R, Trocha A, Altfeld M, He S, Bunce M, Funkhouser R, Pelton SI, Burchett SK, McIntosh K, Korber BT, Walker BD. Nature; 2001 Jul 19; 412(6844):334-8. PubMed ID: 11460164 [Abstract] [Full Text] [Related]
14. Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic. Schellens IM, Navis M, van Deutekom HW, Boeser-Nunnink B, Berkhout B, Kootstra N, Miedema F, Keşmir C, Schuitemaker H, van Baarle D, Borghans JA. AIDS; 2011 Sep 10; 25(14):1691-700. PubMed ID: 21681058 [Abstract] [Full Text] [Related]
16. HIV-specific CD4+ T cells and viremia: who's in control? Jansen CA, van Baarle D, Miedema F. Trends Immunol; 2006 Mar 10; 27(3):119-24. PubMed ID: 16458605 [Abstract] [Full Text] [Related]
17. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection. Brumme ZL, Tao I, Szeto S, Brumme CJ, Carlson JM, Chan D, Kadie C, Frahm N, Brander C, Walker B, Heckerman D, Harrigan PR. AIDS; 2008 Jul 11; 22(11):1277-86. PubMed ID: 18580606 [Abstract] [Full Text] [Related]
18. Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes. Kloverpris H, Karlsson I, Bonde J, Thorn M, Vinner L, Pedersen AE, Hentze JL, Andresen BS, Svane IM, Gerstoft J, Kronborg G, Fomsgaard A. AIDS; 2009 Jul 17; 23(11):1329-40. PubMed ID: 19528789 [Abstract] [Full Text] [Related]
19. Association between HIV-specific T helper responses and CTL activities in pediatric AIDS. Wasik TJ, Wierzbicki A, Whiteman VE, Trinchieri G, Lischner HW, Kozbor D. Eur J Immunol; 2000 Jan 17; 30(1):117-27. PubMed ID: 10602033 [Abstract] [Full Text] [Related]
20. Patient-specific cytotoxic T-lymphocyte cross-recognition of naturally occurring variants of a human immunodeficiency virus type 1 (HIV-1) p24gag epitope by HIV-1-infected children. Buseyne F, Chaix ML, Rouzioux C, Blanche S, Rivière Y. J Virol; 2001 May 17; 75(10):4941-6. PubMed ID: 11312369 [Abstract] [Full Text] [Related] Page: [Next] [New Search]